Philippine CovovaxTM distributor Faberco Life Sciences, citing the results released by Novavax in the US, today said that the vaccine provides 100 % protection against severe cases of COVID 19 and 96.4 percent efficacy against original strain of COVID-19.
- Monday, May 11, 2026